| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/06/1994 | EP0590058A1 Method for making humanized antibodies |
| 04/06/1994 | EP0590030A1 A receptor-type tyrosine kinase [human eph/elk-like kinase - hek] and use thereof |
| 04/06/1994 | EP0589975A1 New selective aromatase inhibiting 4(5)-imidazoles |
| 04/06/1994 | EP0423195B1 Purified hematoporphyrin trimers useful in photodynamic therapy |
| 04/05/1994 | US5300671 Gem-diphosphonic acids, and pharmaceutical compositions containing them |
| 04/05/1994 | US5300525 Anti-solid tumor agents |
| 04/05/1994 | US5300522 Condensed heterocyclic compounds and pharmaceutical use thereof |
| 04/05/1994 | US5300501 Metalloproteinase inhibitors |
| 04/05/1994 | US5300294 Administering a steroid 5-a-reductase inhibiting compound |
| 04/03/1994 | CA2107548A1 Anti-arrhythmic, analgesically acting phthalazinone derivatives that break through multi-drug resistance |
| 04/03/1994 | CA2107514A1 Acylsulfonamido- and sulfonamidopyridine-2-carboxylic acid esters and their pyridine n-oxides, processes for their preparation and their use as medicaments |
| 04/02/1994 | CA2100808A1 Deoxy paclitaxels |
| 03/31/1994 | WO1994007142A1 Up-converting reporters for biological and other assays using laser excitation techniques |
| 03/31/1994 | WO1994006916A1 Gene transcription and ionizing radiation: methods and compositions |
| 03/31/1994 | WO1994006910A1 Gene therapy by retroviral vector with tumor suppressive gene |
| 03/31/1994 | WO1994006909A2 A method of preventing tumor metastasis |
| 03/31/1994 | WO1994006820A1 Leukinferon preparation |
| 03/31/1994 | WO1994006818A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 03/31/1994 | WO1994006795A1 2-aminoalkyl-5-aminoalkylamino substituted isoquinoindazole-6-(2h)-ones with antitumour activity |
| 03/31/1994 | WO1994006786A1 2-(1-HYDROXYETHYL)-5-HYDROXYNAPHTO[2,3-b]FURAN-4,9-DIONE AND ANTITUMOR AGENTS COMPRISING THIS COMPOUND |
| 03/31/1994 | WO1994006771A1 1,2 DIHYDRO-3-H-DIBENZ(de,h) ISOQUINOLINE 1,3 DIONE AND THEIR USE AS ANTICANCER AGENTS |
| 03/31/1994 | WO1994006770A1 N-cyano-n'-pyridylguanidines as serotonin antagonists |
| 03/31/1994 | WO1994006762A1 Non-metabolizable clomiphene analogs for treatment of tamoxifen-resistant tumors |
| 03/31/1994 | WO1994006761A1 Benzenealkanoic acids for cardiovascular diseases |
| 03/31/1994 | WO1994006431A1 Novel epoxide-containing compounds |
| 03/31/1994 | WO1994006424A1 Transcutaneous in vivo activation of photosensitive agents in blood |
| 03/31/1994 | WO1994006422A1 Use of taxol for treating lymphomas and breast cancer |
| 03/31/1994 | WO1994003611A3 Ptp-d subfamily of protein tyrosine phosphatases |
| 03/31/1994 | WO1993023549A3 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors |
| 03/31/1994 | DE4232739A1 Neue asymmetrisch substituierte bis-Naphthalimide New asymmetrically substituted bis-naphthalimide |
| 03/31/1994 | CA2145412A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 03/31/1994 | CA2145192A1 Novel epoxide-containing compounds |
| 03/31/1994 | CA2145190A1 Use of taxol for treating lymphomas and breast cancer |
| 03/31/1994 | CA2144856A1 A method of preventing tumor metastasis |
| 03/31/1994 | CA2144848A1 Gene therapy by retroviral vector with tumor suppressive gene |
| 03/31/1994 | CA2144049A1 1,2-dihydro-3h-dibenzisoquinoline-1,3-dione anticancer agents |
| 03/30/1994 | EP0589719A1 Modified platelet factor-4 |
| 03/30/1994 | EP0589473A1 Hydroxyphosphinyl phosphonate squalene synthetase inhibitors and their use in pharmaceutical compositions |
| 03/30/1994 | EP0589336A1 Benzoylguanidines, process for their preparation and their use as antiarrhythmic agents |
| 03/30/1994 | EP0588915A1 Azulenic retinoid compounds, compositions and methods |
| 03/30/1994 | EP0588905A1 Radiolabelled somatostatin derivatives, their preparation and use |
| 03/30/1994 | CN1084408A Cyclic adhesion inhibitors |
| 03/30/1994 | CN1084391A Surface modified anticancer nanoparticles |
| 03/29/1994 | US5298400 Genetic engineering and gene expression |
| 03/26/1994 | CA2106716A1 Process for preparing 4-hydroxypyrrolo(2,3-d) pyrimidine based antifolate compounds and intermediates |
| 03/26/1994 | CA2106629A1 Modified platelet factor-4 |
| 03/26/1994 | CA2104748A1 Hydroxyphosphinyl phosphonate squalene synthetase inhibitors and method |
| 03/24/1994 | CA2106446A1 Bu-4803t antibiotics |
| 03/23/1994 | EP0588762A1 Use of pyrimidine derivatives as inhibitors of proteinkinase C and antitumor drugs |
| 03/23/1994 | EP0588621A2 Neutral lipids from endosperm of job's tears and compositions including them |
| 03/23/1994 | EP0588317A1 Uridine derivative and process for preparing the same |
| 03/23/1994 | EP0587749A1 Compositions and delivery systems for transdermal administration of neutral oligomers |
| 03/23/1994 | EP0587735A1 T cell receptor peptides as therapeutics for immune-related disease |
| 03/23/1994 | EP0587555A1 A bifunctional dtpa-type ligand |
| 03/23/1994 | EP0464124B1 A peptide, immunogenic composition and vaccine or medicinal preparation; a method of immunising a mammal against lhrh, and a method of improving the meat quality of pigs |
| 03/23/1994 | EP0433360B1 Improvements relating to the production of prodrugs |
| 03/23/1994 | EP0416014B1 Liposome-encapsulated vinca alkoaloids and their use in combatting tumors |
| 03/23/1994 | CN1084178A 2'-deoxy-2'-2'-difluoro(2,6,8-substituted) purine nucleosides having anti-viral and anti-cancer activity and intermediates |
| 03/23/1994 | CN1084177A 2'-deoxy-2',2'-difluoro(4-substituted pyrimidine) nucleosides having anti-viral and anti-cancer activity and intermediates |
| 03/23/1994 | CN1084175A Novel phospholipid derivatives |
| 03/22/1994 | US5296616 Optically active fluorine-containing compound |
| 03/22/1994 | US5296589 Dissolving in nonreactive solvent, reacting with hydrogen, palladium chloride, hydrochloric acid in sealed vessel at elevated pressure, removing palladium chloride, neutralizing, separating product |
| 03/22/1994 | US5296237 Water-soluble pharmaceutical metallocene-complex composition |
| 03/22/1994 | US5296231 Producing liposome encapsulated DNA repair enzyme |
| 03/17/1994 | WO1994005804A1 Maspin, a novel serpin with tumor suppressing activity |
| 03/17/1994 | WO1994005792A1 Self-assembling recombinant papillomavirus capsid proteins |
| 03/17/1994 | WO1994005630A1 1α,24(S)-DIHYDROXY VITAMIN D2, ITS FORMATION AND USE |
| 03/17/1994 | WO1994005333A1 Oligonucleotide modulation of cell adhesion |
| 03/17/1994 | WO1994005329A1 Stimulation of an antitumor t-cell response using anti-idiotypic antibodies |
| 03/17/1994 | WO1994005315A1 Treatment of tumors with neurotrophic factors and cell proliferation inhibitors |
| 03/17/1994 | WO1994005310A1 Peptide inhibitors of cellular adhesion |
| 03/17/1994 | WO1994005299A1 Medicinal composition |
| 03/17/1994 | WO1994000095A3 Use of calpain inhibitors in the inhibition and treatment of medical conditions associated with increased calpain activity |
| 03/17/1994 | WO1993025530A3 Vinyl arenas having retinoid-like activity |
| 03/17/1994 | CA2144180A1 Peptide inhibitors of cellular adhesion |
| 03/17/1994 | CA2143748A1 Oligonucleotide modulation of cell adhesion |
| 03/17/1994 | CA2143188A1 Maspin, a novel serpin with tumor suppressing activity |
| 03/17/1994 | CA2141935A1 Treatment of tumors with neurotrophic factors and cell proliferation inhibitors |
| 03/17/1994 | CA2139743A1 Stimulation of an antitumor t-cell response using anti-idiotypic antibodies |
| 03/17/1994 | CA2122342A1 Pharmaceutical composition |
| 03/16/1994 | EP0587134A2 Cyclic urea derivatives, medicaments containing them and process for their preparation |
| 03/16/1994 | EP0586917A1 Substituted phenols, process for their preparation and their use in the treatment of all proliferation associated diseases |
| 03/16/1994 | EP0586608A1 Tricyclic polyhydroxylic tyrosine kinase inhibitors |
| 03/16/1994 | EP0586537A1 Substituted n-carboxyalkylpeptidyl derivatives as antidegenerative active agents |
| 03/16/1994 | EP0586535A1 Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers |
| 03/16/1994 | EP0586523A1 Determination of prodrugs metabolizable by the liver and therapeutic use thereof |
| 03/16/1994 | EP0586479A1 Dihydroxyindanone tyrosine kinase inhibitors |
| 03/16/1994 | EP0465512B1 Regional chemotherapy with 4-hydroperoxycyclophosphamide |
| 03/16/1994 | EP0454728B1 Fluorinated flavone acetic acid |
| 03/16/1994 | EP0445206B1 Hydroxamic acid based collagenase inhibitors |
| 03/16/1994 | EP0429624B1 RADIOIMMUNOTHERAPY USING $g(a)-PARTICLES EMISSION |
| 03/16/1994 | EP0391971B1 Improving toxicity profiles in chemotherapy |
| 03/16/1994 | CN1083817A Water soluble camptothecin analogs |
| 03/16/1994 | CN1024007C Fused pyrimidines, their production and use |
| 03/15/1994 | US5294723 Antitumor, immunology |
| 03/15/1994 | US5294701 Anthracycline compounds and intermediates |
| 03/15/1994 | US5294615 Crystalline 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine monohydrochloride |
| 03/15/1994 | CA1327869C Ribonucleotide reductase inhibitors |
| 03/15/1994 | CA1327745C Product containing as active ingredients : a) a peptide having a human immune interferon like activity, b) hydroxyurea |
| 03/12/1994 | CA2105934A1 Cyclic urea derivatives |